跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,896 条关于
“Kiora Pharmaceuticals”
全部
8,896
临床试验
531
药物
1,725
机构
2,044
资讯
4,596
去年
Kiora Pharmaceuticals Advances Retinal Disease Pipeline with Positive Q3 Results
去年
Kiora Pharmaceuticals Receives IND Approval for KIO-301 Phase 2 Retinitis Pigmentosa Trial
去年
Kiora Pharmaceuticals Advances Two Phase 2 Retinal Disease Trials, Secures $110M Asian Partnership
去年
Kiora Pharmaceuticals Receives IND Approval for KIO-301 Phase 2 Trial in Retinitis Pigmentosa
9个月前
Kiora Pharmaceuticals Secures New Patent for KIO-104 Formulations, Extending Market Protection to 2043
10天前
Kiora Pharmaceuticals Appoints Keith J. Lane as EVP of Global Clinical Development and Regulatory Affairs
去年
Kiora Pharmaceuticals Advances KIO-104 to Phase 2 Trial for Retinal Macular Edema Treatment
去年
Kiora Pharmaceuticals Partners with Senju for KIO-301 Development in Asian Markets Worth Over $110 Million
2个月前
First-in-Human Trial of Photoswitch Drug Shows Promise for Restoring Vision in Retinitis Pigmentosa
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
第 1 页,共 460 页
上一页
下一页